webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Biotin-PEG2-acid

  CAS No.: 1365655-89-5   Cat No.: BADC-00935   Purity: >98.0% 4.5  

Biotin-PEG2-acid combines a biotin tag with a short PEG linker, ideal for ADCs and affinity-based purification. It enables avidin-biotin interaction, facilitating antibody targeting, detection, or capture in bioconjugation and drug delivery applications.

Biotin-PEG2-acid

Structure of 1365655-89-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C17H29N3O6S
Molecular Weight
403.49
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(+)-Biotin-PEG2-acid; (+)-Biotin-PEG2-COOH; 3-(2-(2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)ethoxy)ethoxy)propanoic acid
IUPAC Name
3-[2-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C1C2C(C(S1)CCCCC(=O)NCCOCCOCCC(=O)O)NC(=O)N2
InChI
InChI=1S/C17H29N3O6S/c21-14(18-6-8-26-10-9-25-7-5-15(22)23)4-2-1-3-13-16-12(11-27-13)19-17(24)20-16/h12-13,16H,1-11H2,(H,18,21)(H,22,23)(H2,19,20,24)/t12-,13-,16-/m0/s1
InChIKey
SDOAIZRTYJIBBG-XEZPLFJOSA-N
Density
1.2±0.1 g/cm3
Solubility
10 mm in DMSO
Flash Point
408.7±32.9 °C
Index Of Refraction
1.527
Vapor Pressure
0.0±5.4 mmHg at 25°C
Appearance
Solid
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C
Boiling Point
752.2±60.0 °C at 760 mmHg
Form
Solid

Biotin-PEG2-acid, a versatile bifunctional molecule central to bioconjugation and biotechnology, finds diverse applications. Here are four key uses of Biotin-PEG2-acid presented with high perplexity and burstiness:

Protein Labeling: Employing Biotin-PEG2-acid enables precise protein labeling, facilitating detection and purification via robust streptavidin-biotin interactions. This technique proves invaluable in affinity chromatography, selectively isolating biotinylated proteins from complex mixtures. The PEG2 spacer plays a pivotal role, enhancing solubility and reducing steric hindrance, ultimately optimizing protein binding efficiency and detection accuracy.

Drug Delivery Systems: Enter the realm of targeted drug delivery systems, where Biotin-PEG2-acid emerges as a key player. By conjugating therapeutic agents to biotin, drug compounds can be guided to specific cells or tissues expressing biotin-binding proteins. The PEG2 linker takes the stage, enhancing biocompatibility and circulation time, bolstering the therapeutic efficacy of the conjugated drugs.

Immunoassays: In the realm of immunoassay development, Biotin-PEG2-acid takes center stage in biotinylating antibodies or antigens, employing streptavidin-coated surfaces for detection. This approach finds widespread use in diagnostic assays like ELISAs and western blots, owing to the high affinity and specificity of the biotin-streptavidin interaction. The PEG2 spacer serves as a critical ally, minimizing non-specific binding and elevating assay sensitivity and precision.

Cell Surface Modification: Witness the transformative potential of Biotin-PEG2-acid in cell surface modification through biotinylation of cell membrane proteins. This strategic move allows for precise attachment of streptavidin-conjugated molecules, such as fluorescent probes or nanoparticles, onto the cell surface. This technique unlocks opportunities for cell labeling, tracking, and targeted imaging studies, shedding light on intricate cell behaviors and interactions.

What is the primary application of Biotin-PEG2-acid in ADCs?

Biotin-PEG2-acid serves as a functional linker enabling biotinylation of antibodies or ADCs. Its PEG2 spacer enhances solubility and reduces steric hindrance, facilitating subsequent binding to avidin or streptavidin-based detection and purification systems.

23/9/2020

We are interested in how Biotin-PEG2-acid affects ADC conjugation efficiency.

The carboxylic acid group of Biotin-PEG2-acid enables efficient coupling to amino groups on antibodies using standard carbodiimide chemistry. The PEG2 spacer reduces steric interference, improving conjugation yield and reproducibility.

11/9/2021

Could you advise if Biotin-PEG2-acid is suitable for in vivo applications?

Yes, Biotin-PEG2-acid is suitable for in vivo use when applied in controlled biotin-streptavidin systems. The PEG2 spacer enhances solubility and reduces non-specific interactions, supporting targeted delivery or imaging studies.

9/6/2022

Dear BOC Sciences, which analytical techniques can verify Biotin-PEG2-acid incorporation?

Incorporation of Biotin-PEG2-acid can be confirmed by HPLC for purity, mass spectrometry for molecular weight verification, and streptavidin-binding assays to ensure functional biotin presentation on the conjugate.

1/1/2018

Dear BOC Sciences, how should Biotin-PEG2-acid be stored to preserve its functional integrity?

Biotin-PEG2-acid should be stored at low temperature in a dry, light-protected environment. Inert atmosphere or vacuum-sealed containers are recommended to prevent hydrolysis. Proper handling with gloves and protective equipment ensures stability. Supporting documents provide detailed storage guidelines.

6/4/2022

— Dr. Jonathan White, Medicinal Chemist (UK)

Biotin-PEG2-acid offered excellent biotinylation efficiency for our ADC constructs.

9/6/2022

— Ms. Anna Hoffmann, Biochemist (Germany)

High purity and solubility ensured smooth conjugation across different biomolecules.

6/4/2022

— Dr. William Parker, Senior Scientist (USA)

We achieved reproducible labeling without side reactions.

1/1/2018

— Dr. Elise Moreau, Chemist (France)

Reliable incorporation in multi-step workflows simplified our linker design.

23/9/2020

— Dr. Mark Johnson, Research Scientist (USA)

The product enabled innovative targeting strategies using biotin-streptavidin chemistry.

— Dr. Rachel Adams, Bioconjugation Scientist (USA)

Biotin-PEG2-acid from BOC Sciences enabled efficient biotinylation of our proteins. The high purity and well-documented handling instructions were very helpful.

11/9/2021

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: BCN-PEG4-OH | 7-Xylosyl-10-deacetyltaxol | (+)-CBI-CDPI2 | N-Ac-Cys-MC-VC-PAB-MMAE | NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 | Br-PEG4-NHBoc | Fmoc-Ala-Ala-PAB | Irofulven | 6-Maleimidocaproic acid | 14-Benzoyltalatisamine Perchlorate | Biotin-PEG2-acid
Send Inquiry
Verification code
Inquiry Basket